Bottom line summary of why I say it's flawed, from a return to shareholders perspective, you should work your numbers out on EBITDA and not NPAT (especially a crude estimate that ignores debt repayment).
if you redo your analysis using EBITDA you will find that the investment actually looks very attractive.
Bottom line summary of why I say it's flawed, from a return to...
Add SFX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.003(0.85%) |
Mkt cap ! $116.4M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 30.0¢ | 29.5¢ | $18.61K | 62.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8858 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 2068 | 1 |
View Market Depth
| Last trade - 15.37pm 17/10/2024 (20 minute delay) ? |
| SFX (ASX) Chart |